Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;16(5):465-470.
doi: 10.1080/1744666X.2020.1750954. Epub 2020 Apr 6.

Immune-epidemiological parameters of the novel coronavirus - a perspective

Amene Saghazadeh  1   2 , Nima Rezaei  3   4   5
Affiliations
Review

Immune-epidemiological parameters of the novel coronavirus - a perspective

Amene Saghazadeh et al. Expert Rev Clin Immunol. 2020 May.

Abstract

Introduction: At the end of 2019, Wuhan, a city in China with a population of about 11 million, witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has spread to more 199 countries and territories worldwide. The 2019 novel coronavirus, 2019-nCoV, is known as the probable causative agent of the illness.

Areas covered: Here, the epidemiological dynamics of the coronavirus disease 2019 (COVID-19) that stand in close relation to distinct immunogenetic characters of the pathogen are discussed, to understand the ability and inability of the immune system in combatting COVID-19.

Expert opinion: The elderly population is at increased risk of developing and dying from COVID-19. Comorbidity is present in more than 30% of cases with COVID-19. Except for less than 1% of the total, a chronic condition has been found in all cases that died from COVID-19. Men are more than 1.5 times more likely to die from COVID-19. Evidence links aging to cytokine dysregulation and T-cell repertoire reduction, male population to relatively reduced anti-viral immunity, and COVID-19-related comorbidities to hyper inflammation. The transmission of COVID-19 is influenced by the host-related factors that are known to be associated with immune dysregulation.

Keywords: 2019-nCoV; COVID-19; Novel coronavirus; SARS-CoV2; immune-epidemiology.

PubMed Disclaimer

References

    1. Zumla A, Hui DS, Perlman S.. Middle East respiratory syndrome. Lancet. 2015;386(9997):995–1007. - PMC - PubMed
    1. Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362(9380):263–270. - PMC - PubMed
    1. Aoshi T, Koyama S, Kobiyama K, et al. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol. 2011. October 01;1(4):226–232. - PubMed
    1. Arpaia N, Barton GM.. Toll-like receptors: key players in antiviral immunity. Curr Opin Virol. 2011. December 01;1(6):447–454. - PMC - PubMed
    1. Bonjardim CA. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses—and viruses counteract IFN action. Microbes Infect. 2005. March 01;7(3):569–578. - PubMed